Showing the single result
Citicoline Tablets
FreeProduct Composition & Strength
We supply this product as Controlled Release (CR) Tablets (Film Coated). The matrix formulation is critical to extend the biological half-life.
Active Ingredient Strength Release Profile Primary Indication Citicoline Sodium USP/IP 500 mg Controlled Release Mild Cognitive Impairment / Maintenance Citicoline Sodium USP/IP 1000 mg Controlled Release Acute Stroke Recovery / Severe Dementia Excipients Q.S. HPMC (Release Retardant) / Magnesium Stearate Matrix System
